Related Experiment Video
Updated: Feb 5, 2026

Simple Continuous Glucose Monitoring in Freely Moving Mice
Published on: February 24, 2023
Targeting glucose control in preterm infants: pilot studies of continuous glucose monitoring
Lynn Thomson1,2, Daniela Elleri1,3, Simon Bond3
1Department of Paediatrics, University of Cambridge, Cambridge, UK.
Insights
Continuous glucose monitors (CGM) are feasible and safe for preterm infants, improving glucose control and reducing hyperglycemia. This supports their use in future randomized controlled trials for neonatal care.
Area of Science:
- Neonatal Medicine
- Endocrinology
- Medical Devices
Background:
- Hyperglycemia is frequent in very preterm infants, linked to poor outcomes.
- Balancing hyperglycemia prevention with hypoglycemia risk is challenging.
- Continuous glucose monitoring (CGM) offers potential for improved glucose management.
Purpose of the Study:
- Assess the feasibility and safety of CGM in preterm infants.
- Inform the design of a future randomized controlled trial (RCT).
- Evaluate CGM's accuracy and clinical utility for glucose control.
Main Methods:
- Single-center study in very preterm infants during the first week of life.
- Accuracy assessed by comparing CGM with blood glucose levels (n=20).
- Pilot efficacy study (n=20) comparing real-time CGM with standard care (masked CGM).
Main Results:
- CGM showed good accuracy compared to point-of-care measurements (mean bias -0.27).
- Increased time in target glucose range (77% vs 59%) and decreased hyperglycemia with CGM.
- CGM detected unsuspected hypoglycemia; staff found it improved clinical care.
Conclusions:
- CGM demonstrates sufficient accuracy and utility in preterm infants.
- The findings support further investigation in a randomized controlled trial.
- CGM is a promising tool for neonatal glucose management.
Objective:
Hyperglycaemia is common in very preterm infants and is associated with adverse outcomes. Preventing hyperglycaemia without increasing the risk of hypoglycaemia is difficult. Real time tracking with continuous glucose monitors (CGM) may improve glucose control. We assessed the feasibility and safety of CGM to target glucose control in preterm infants, to inform a randomised controlled trial (RCT).
Design:
We performed a single centre study in very preterm infants during the first week of life. Accuracy was assessed by comparison of CGM with blood glucose levels (n=20 infants). In a separate pilot study of efficacy (n=20), real-time CGM combined with a paper guideline to target glucose control (2.6-10 mmol/L) was compared with standard neonatal care (masked CGM). Questionnaires were used to assess staff acceptability.
Results:
No concerns were raised about infection or skin integrity at sensor site. The sensor performed well compared with point-of-care blood glucose measurements, mean bias of -0.27 (95% CI -0.35 to -0.19). Per cent time in target range (sensor glucose 2.6-10 mmol/L) was greater with CGM than POC (77% vs 59%, respectively) and per cent time sensor glucose >10 mmol/L was less with CGM than POC (24% vs 40%, respectively). The CGM also detected clinically unsuspected episodes of hypoglycaemia. Staff reported that the use of the CGM positively improved clinical care.
Conclusions:
This study suggests that CGM has sufficient accuracy and utility in preterm infants to warrant formal testing in a RCT.
More Related Videos
08:32Studying the Hypothalamic Insulin Signal to Peripheral Glucose Intolerance with a Continuous Drug Infusion System into the Mouse Brain
Published on: January 4, 2018
06:11Author Spotlight: Exploring the Long-Term Health Impacts of Intracytoplasmic Sperm Injection on Offspring
Published on: May 17, 2024
Related Concept Videos
Glucose Homeostasis: Regulation of Blood Glucose
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
Glucose Transporters
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Glucose Absorption Into the Small Intestine
Hormones Regulating Blood Glucose
In addition to accelerating glucose uptake and utilization, insulin has...
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
Insulin and C-peptide are...
Pilot and Numeric Relaying